Literature DB >> 3971535

Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction.

J E Nordrehaug, K A Johannessen, G von der Lippe.   

Abstract

Sixty patients with a first acute myocardial infarction and no current treatment with cardioactive drugs were included in a prospective study of the relationship between serum potassium concentration and the early occurrence of ventricular tachycardia and premature ventricular contractions (PVCs). Serum potassium level (range 2.5 to 5 mmol/liter) was estimated 3.8 +/- 2.5 hr (mean +/- SD) after the onset of the infarction, and Holter monitoring was performed during the subsequent 12 hr. In multivariate analysis, serum potassium level was negatively and age positively related to ventricular tachycardia. Among the subclasses of PVCs (frequent unifocal, multifocal, couplets, bigeminy), serum potassium concentration was negatively related to the frequent unifocal subclass; hypertension was related to couplets and to the presence of any of the subclasses, and serum aspartate aminotransferase concentration was related to multifocal PVCs. Heart failure leading to death was related to all subclasses of PVC. Serum potassium concentration is an independent inverse predictor of the occurrence of ventricular tachycardia and frequent unifocal PVCs early in acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971535     DOI: 10.1161/01.cir.71.4.645

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

Review 1.  Drug-induced hypokalaemia. A cause for concern.

Authors:  G Isaac; O B Holland
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

Review 2.  Diuretic-induced hypokalaemia and surgery: much ado about nothing?

Authors:  L J Restrick; N Huddy; B I Hoffbrand
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

3.  Effect of diabetes on serum potassium concentrations in acute coronary syndromes.

Authors:  K Foo; N Sekhri; A Deaner; C Knight; A Suliman; K Ranjadayalan; A D Timmis
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

4.  Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.

Authors:  B J Lipworth; D G McDevitt; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

5.  Electrocardiographic findings of life-threatening hypokalaemia.

Authors:  K R Ramachandran; W K Lagrand; A Dirkali
Journal:  Neth Heart J       Date:  2005-08       Impact factor: 2.380

6.  Variations in potassium concentration modify the inhibitory effect of lorcainide on myocardial Na(+)-K(+)-ATPase activity.

Authors:  A A Almotrefi; N Dzimiri
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

7.  The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.

Authors:  Fawaz F Alharbi; Patrick C Souverein; Mark C H de Groot; Marieke T Blom; Anthonius de Boer; Olaf H Klungel; Hanno L Tan
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

Review 8.  Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

Authors:  Shelley R Salpeter
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.

Authors:  P Bremner; C Burgess; G Purdie; R Beasley; J Crane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 10.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.